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Classical  tissue  engineering  is  aimed  mainly  at  producing  anatomically  and  physiologically  
realistic  replacements  for  normal  human  tissues.  It   is  done  either  by  encouraging  cellular  
colonization   of  manufactured  matrices   or   cellular   recolonization   of   decellularized   natural  
extracellular  matrices  from  donor  organs,  or  by  allowing  cells  to  self-­organize  into  organs  
as  they  do  during  foetal  life.  For  repair  of  normal  bodies  this  will  be  adequate  but  there  are  
reasons   for   making   unusual,   non-­evolved   tissues   (repair   of   unsual   bodies,   interface   to  
electro-­mechanical   prostheses,   incorporating   living   cells   into   life-­support   machines).  
Synthetic   biology   is   aimed  mainly   at   engineering   cells   so   that   they   can   perform   custom  
functions:  applying  synthetic  biological  approaches  to  tissue  engineering  may  be  one  way  
of   engineering   custom   structures.   In   this   article,   we   outline   the   'embryological   cycle'   of  
patterning,  differentiation  and  morphogenesis,  and  review  progress  that  has  been  made  in  
constructing  synthetic  biological  systems  to  reproduce  these  processes  in  new  ways.  The  
state-­of-­the-­art  remains  a  long  way  from  making  truly  synthetic  tissues,  but  there  are  now  










Synthetic   biology   has   so   far   been   dominated   by   systems   that   operate   at   the   single-­cell  
level.  Much  engineering  work,   for   example   constructing  modules   for   new  metabolism  or  
bio-­sensing,  has  been  done  in  single-­celled  micro-­organisms  with  little  or  no  possibility  for  
multicellular   organization   (examples  may   be   found   in   [1-­3])   and,   even   where   host   cells  
from  multicellular  organisms  such  as  animals  and  plants  have  been  used,  multicellularity  
has   usually   been   irrelevant   to   the   aims   of   the   project.   A   few   projects   have,   however,  
focused   on   the   behaviour   of   cell   collectives,   for   example   to   synchronise   synthetic  
oscillators   [4]   or   to   orchestrate   simple   multicellular   morphogenetic   events   [5].   These  
projects   have   demonstrated   the   feasibility   of   constructing   mechanisms   that   use  
cooperative  actions  of  engineered  cells  and,  we  argue  in  this  article,  open  the  door  to  the  
application   of   synthetic   biological   techniques   to   the   challenges   of   advanced   tissue  
engineering.      
  
Conventional  tissue  engineering  
Tissue   engineering   is   a   multi-­disciplinary   endeavour   and   its   aim   is   to   construct   or   re-­
construct  tissues  for  the  repair  of  bodies  that  are  damaged  or  in  some  way  unusual  [6].  Its  
challenges  vary  in  scale  from  construction  of  relatively  simple  tissues  to  complex  organs.  
An  example  of  the  relatively  simple  is  cartilage,  an  avascular  tissue  that  contains  few  cell  
types   and   a   relatively   homogenous   matrix,   and   which   can   be   valuable   to   surgeons   for  
engraftment   into   damaged   joints   [7].   An   example   of   the   very   complex   is   the   kidney,   a  
highly  complex  system  of  fine  tubes  and  filters  arranged  with  great  precision  with  respect  
to  one  another  and  with  respect  to  vasculature,  and  that  contains  at  least  60  distinct  tissue  
types   [8].   Cartilage   engineering   has   reached   a   stage   of   maturity   that   has   seen   direct  
clinical   application   [7].   Kidney   engineering   is,   not   surprisingly,   still   at   the   stage   of   fairly  
crude  demonstrations  in  culture  and  in  animals  [9,10].    
  
There  are  three  main  approaches  to  tissue  engineering.  One  approach  places  the  greatest  
creative   load   on   the   engineers   themselves,   who   create   template   structures   by   casting,  
electro-­spinning,  or  3-­dimensional  printing  and  then  seed  them  with  living  cells  [11,12].  So  
far,   this   has   been   most   effective   for   simple   structures.   Another   approach   places   the  
creative  load  on  natural  development  and  uses  complex  tissue  structures  from  a  deceased  
organ  donor:  a  donated  tissue  or  organ  is  cleared  of  cells  by  a  method  that  preserves  the  
extracellular  matrix,  and  fresh  cells  (for  example,  patient-­derived  stem  cells)  are  placed  in  
that   'ghost'  matrix  and  so  adhere   to   its  complex  anatomy.  This  method  has  seen  clinical  
use   for   structures   of   moderate   complexity   such   as   trachea   [13].   The   third   approach  
capitalizes  on  the  self-­organizing  ability  of  many  cell  types,  and  the  most  realistic  kidneys  
engineered   to  date  have  been  made  by  bringing  kidney-­forming  stem  cells   together  and  
using   drugs   to   suppress   anoikis   (a   type   of   elective   cell   death)   while   they   organize  
themselves  into  a  mini-­kidney  in  much  the  same  way  that  they  would  organize  themselves  
during  foetal  life  [14,15].    
  
All  of  these  methods  have  been  designed  to  produce  tissues  that  are  as  anatomically  and  
physiologically  normal  as  possible,  although  the  first  approach  could  in  principle  be  used  to  
make  deliberately  abnormal  tissues.  This  goal  that  may  be  much  more  reasonable  than  it  
first  sounds.  
  
The  case  for  extending  tissue  engineering  beyond  the  normal  
Normal   tissues   have   their   limitations.   They   are   ideally   suited   to   replace   a   damaged   or  
worn-­out  part   in  an  anatomically  typical  body,  but  some  bodies  are  unusual.  People  born  
with   congenital   abnormalities   may   require   anatomically   or   physiologically   customized  
engineered   tissues   to   lead   normal   lives;;   people  with   autoimmune   diseases  may   require  
physiological   functions   such   as   insulin   production   to   be   placed   in   safe   cell   types   rather  
than   immune-­targeted   cells;;   people   with   advanced   artificial   limbs   or   sense-­organs   may  
require  specialized  interface  tissues  between  natural  nervous  system  and  machine;;  people  
dependent,   even   temporarily,   on   ex-­corporo   life-­support   machines   may   benefit   greatly  
from  physiologically  active  'tissues'  housed  in  those  machines;;  and  even  for  conventional  
tissue   engineering,   synthetic   niches   that   are   well   adapted   to   culture   conditions  may   be  
very  useful  in  growing  stem  cells  and  differentiating  them  towards  a  desired  fate.    
  
None   of   these   custom   'tissues'   are   natural   outcomes   of   our   evolved   developmental  
mechanisms,   so   their   production   requires   deliberate   interference   with   cells,   their  
environment,  or  both.  For   relatively  simple  examples   that   require  custom  anatomy  but   in  
which   cell   physiology   is   normal,   the   techniques   of   casting,   spinning   or   printing   matrix  
supports  in  the  shape  of  the  required  anatomy  may  be  enough.  For  structures  beyond  the  
limits  of  direct  fabrication,  or  beyond  the  limits  of  cells  to  navigate  and  colonize  fabricated  
structures,   and   where   cell   physiology   itself   needs   to   be   unusual,   a   directly   synthetic  
biological  approach  will  be  needed.  
  
Self-­organizing  synthetic  'tissues':  a  feasible  goal?  
Normal   embryonic   development   consists,   in   the   main,   of   three   processes   that   operate  
cyclically  (Fig  1).  One  is  patterning,  which  can  create  differences  between  cells  that  were  
identical,   either   de   novo,   as   in   the   pattern   of   feathers   on   chick   skin   [16],      or   as   a   finer  
elaboration   of   an   existing   coarse   pattern,   as   in   the   segmentation   of   the   fruit   fly   [17].   A  
common   result   of   patterning   is   cell   differentiation,   a   stable   change   in      gene   expression  
according   to   the   patterning   signals.   Some   changes   in   gene   expression   drive   the   third  
process,  morphogenesis,   the  creation  of  anatomical   form.  Morphogenesis,  which   for  our  
purposes  can  be  taken  to  include  growth,  creates  differently  shaped  and  sometimes  larger  
fields  of  cells  and,  by   folding  of  sheets  and  by  cell  migration,  can  bring  distant  cells   into  
proximity.   These   processes   can   trigger   new   patterning   events   that   in   turn   drive   new  
differentiation  and  yet  more  morphogenesis.  Thus  the  three  processes  run  in  a  loop,  with  
finer  and  finer  body  details  being  added  on  each  pass.  Typically,  the  first  pass  through  the  
loop   generates   very   coarse   body   features   (such   as   division   into   head   and   trunk),   later  
iterations   generate   finer   patterns   (such   as   division   of   the   trunk   into   segments,   as  
demonstrated   in   our   own   bodies   by   the   series   of   vertebrae),   while   later   iterations   still  
generate  finer  details  such  as  the  pattern  of  hairs  on  skin.    
  
One   approach   to  making   truly   synthetic   tissues   is   to   engineer   artificial   mechanisms   for  
these  processes;;  patterning,  controlled  gene  expression,  and  morphogenesis.  The  rest  of  
this  article  will  be  devoted  to  reviewing  early  progress  in  this  field.  It  will  be  seen  that  only  
the  first,  crude  steps  have  yet  been  taken  in  this  direction  but  that  the  results  appear  to  be  
promising.  
  
Synthetic  biological  patterning  mechanisms  
The   first   synthetic   biological   patterning   systems   built   were   oscillators   that   generated  
patterns   in   time   rather   than   in   space.   This   may   seem   to   be   unrelated   to   the   spatial  
problems  in  tissues  but,  as  it  is  possible  to  transform  patterns  in  time  into  patterns  in  space  
and   vice-­versa,   they   should   be   included.   Indeed,   even   natural   embryogenesis   includes  
clock-­and-­wavefront  models  that  combine  a  clock  with  a  wave  that  sweeps  along  a  tissue,  
and  leaves  a  'mark'  where  the  wave  is,  whenever  the  clock  reaches  a  particular  phase.  An  
example,   albeit   one   with   many   refinements   over   the   simple   system   just   described,   is  
vertebrate  somitogenesis  [18].  Conversely,  a  wave  travelling  along  a  tissue  patterned  with  
a  spatial   repeat  such  as  stripes  could,  by   triggering  expression  of  a  molecule  only  when  
the  wave  is  crossing  one  colour,  generate  a  temporal  pattern  for  the  spatial  one.  The  first  
synthetic   biological   oscillator   was   the   bacterial   'repressilator'   [19],   a   cyclic   sequence   of  
three   genes,   each   of   which   encoded   a   protein   that   would   suppress   transcription   of   the  
gene   ahead   of   it   in   the   cycle   (Fig   2a).   Subsequent   refinements   so   synthetic   oscillators  
have  added  synchronisation  between  cells  [4]  or  between  populations  of  cells  [20].  
  
Some  spatial  patterning  systems  have  also  been  built.  The  first  ones  were  not  capable  of  
generating  patterns  de  novo,  but  could  at  least  elaborate  a  simple  external  cue  into  a  more  
complex   pattern.   One   example   [21]   interpreted   a   simple   spatial   gradient   of   signal  
concentration   to   create   a   stripe   in   the   region   of   moderate   concentration.   It   coupled  
detection   of   the   signal   to   the   activation   of   two   genes:   one,   activated   by   an   efficient  
promoter,   drove   transcription   of   the   final   output   reporter   while   the   other,   activated   by   a  
relatively   inefficient   promoter,   drove   a   repressor   final   output   transcription   (Fig   2b).   In  
regions  of  very  low  concentration,  there  was  too  little  signal  to  drive  the  transcription  of  the  
output  gene.  In  regions  of  moderate  concentration,  there  was  enough  to  drive  the  efficient  
promoter   of   the   output   gene.   In   regions   of   very   high   concentration,   even   the   inefficient  
promoter   of   the   repressor   gene   was   active,   and   transcription   of   the   output   gene   was  
repressed.  The  gene  was  therefore  only  'on'  in  the  zone  of  moderate  signal  concentration.  
A  similar  network  has  been  engineered  in  mammalian  cells  [22].  Again,  refinements  to  this  
system  have  been  made,  and  other  patterning  systems  that  take  their  cues  from  the  edge  
of  bacterial  cultures,  instead  of  manually-­applied  gradients,  have  been  produced  [23].    
  
Patterning   fields   of   cells   de   novo,   with   no   pre-­existing   cues,   is   more   of   a   challenge.  
Attempts  are  underway   to  produce  a  synthetic  version  of  patterning  by   reaction-­diffusion  
mechanisms   thought   to   operate   in   real   embryos   [24,25]   but,   at   the   time   of   writing,   no  
working  system  seems  to  have  published  although  some  promising  tools  already  exist  [26].  
Other   efforts   to   generate   de   novo   patterning   used   orthogonal   control   of   cell   motility   to  
establish   stripes   on   2D   lawns   [27].  Others   have   created   synthetic   circuits   that   could   be  
used   to   generate   lateral-­inhibition   patterns   in  mammalian   cells,   with   components   of   the  
Notch-­Delta  signalling  pathway  [28,29].  We  have  taken  a  different  approach  to  building  a  
de  novo  patterning  system,   that  uses  adhesion-­driven  phase  separation  which   is  not,  as  
far  as  we  know,  widely  used  by  embryos.  The  system  operates  by  cells  expressing  one  of  
two   types   of   calcium-­dependent   adhesion   molecules,   E-­cadherin   or   P-­cadherin.   Cells  
carrying  these  proteins  behave  as  if  E-­cadherin  binding  to  E-­cadherin  reduces  free  energy  
(adheres)   somewhat   more   than   P-­cadherin   to   P-­cadherin,   but   both   reduce   free   energy  
much  more  than  E-­cadherin  to  P-­cadherin  contacts  [30].  It  has  been  known  for  many  years  
that   mixtures   of   low   numbers   of   cells   carrying   these   cadherins   sort   into   homogenous  
groups   to   maximise   homotypic   contacts   and   minimize   energetically   unfavourable  
heterotypic   ones   [31].   This   complete   separation   depends   on   the   system   not   becoming  
trapped  in  a  local  energy  minimum.  Our  computer  modelling  suggested  that  large  numbers  
of  cells  would  become  trapped  in  a  local  minimum,  forming  stripes  or  spots  (depending  on  
cell  ratios)  instead  of  separating  completely.  Constructing  the  system  in  a  human  cell  line  
has   confirmed   this   behaviour,   in   both   2-­dimensional   and   3-­dimensional   culture   systems  
(Fig  3a,b).  The  next  challenge  for  this  system  will  be  to  refine   it  and  add  a  second-­pass,  
elaboration  stage  to  make  a  more  detailed  pattern.  
  
Synthetic  biological  morphogenetic  mechanisms  
The   'developmental   cycle'   (Fig   1)   leads   from   patterning   through   changes   in   gene  
expression   to   morphogenesis.   An   analysis   of   morphogenetic   processes,   in   an   early  
speculative  paper  about  prospects  for  synthetic  morphogenesis  [32],  suggested  that  most  
examples   of   mammalian   morphogenesis   use   combinations   of   about   ten   basic  
morphogenetic  events.  These  are   cell   proliferation,   cell   death,   cell   fusion,   cell   adhesion,  
cell   de-­adhesion,   cell   migration,   epithelial-­to-­mesenchyme   transition,   mesenchyme-­to-­
epithelial   transition,   epithelial   folding   and   lumen   formation.   In   principle,   being   able   to  
invoke  these  events  through  changes  in  gene  expression  following  patterning  would  allow  
the  construction  of  an  artifical  'developmental  cycle'.    
  
Fortunately,  a  range  of  past  studies  had  identified  certain  genes  (some  of  them  from  non-­
embryological  sources,  such  as  viruses),  the  activation  of  which  can  drive  a  specific  one  of  
the  ten  basic  morphogenetic  events.  This  observation  has  allowed  us  to  produce  a  set  of  
modules   for   'synthetic  morphology',   that  allow  control  of  proliferation,  elective  cell  death,  
cell  fusion,  cell  adhesion  and  locomotion  [5].  These  have  been  published  separately  from  
work  on  patterning  but,  in  principle,  morphogenetic  modules  can  be  placed  downstream  of  
patterning.  A  simple  proof-­of-­principle  example  is  shown  in  Fig  3b,  in  which  patterning  by  
phase  separation  is  followed  by  triggering  of  a  cell  death  module  in  one  colour  of  cells  to  
transform  the  pattern  of  colours  into  a  net-­like  arrangement  of  cells  and  spaces.  
  
The  next  steps  
Clearly,   the   demonstrations   described   above,   while   they   do   show   the   feasibility   of  
synthetic  biological  systems  for  patterning  and  morphogenesis,  are  a  long  way  from  being  
useful  synthetic  tissues.  More  patterning  systems  are  clearly  needed,  and  they  need  to  be  
enriched  with  responsive  systems  so  that  patterning  can  be  guided  with  respect  to  outside  
cues.   The   Morphogenetic   systems   are   currently   limited   to   simple   2-­dimensional  
demonstrations;;   additional   modules   to   allow   cells   to   make   multilayered   assemblies   are  
urgently   needed,   as   are   modules   that   encourage   interaction   of   boundary   layers   with  
specific  normal  body  cells.  In  addition,  modules  that  encourage  interaction  with  machinery,  
for  ex-­corporo  applications,  would  be  useful  especially  as  ex-­corporo  applications  are  likely  
to   be   the   first   to   be   translated   to   actual   use   as   the   safety   implications   are   much   less  
troubling  than  they  would  be  for  in  vivo  use.    
  
Classical   tissue   engineering   will   continue   as   synthetic   biology   develops   towards   being  
useful   to   it   and  most   of   the   current   priorities   for   tissue   engineering,  which   all   centre   on  
normal   tissues,   may   probably   achieved   without   a   synthetic   input.   Synthetic   biological  
approaches  may,  however,  make  the  task  easier.  One  of  the  most  promosing  techniques  
for   classical   tisue   engineering   is   bioprinting,   in   which   living   cells   are   laid   down   already  
embedded  in  their  three-­dimensional  matrix  [34].  Bioprinting  has,  for  example,  been  used  
to   produce   3-­dimensional   alginate-­based   matrices   containing   living   human   iPS-­derived  
hepatocyte-­like-­cells,  or   iPS  cells   that  were  differentiated   into  hepatocyte-­like  cells   in  situ  
[35].     Many  printing  processes,  however,  place  serious  stresses  on  cells  due,  depending  
on   the   technique   (eg   inkjet,   extrusion,   laser-­assisted   [34],   to   heat,   shear   stress,   impact,  
and   vibration.   The   need   to   control   these   variables   is   a   serious   limit   on   the   printing  
technolgoies  that  can  be  used,  forcing  sacrifice  of  the  conditions  optimal  for  printing  for  the  
sake   of   keeping   stresses   low.   In   general,   methods   have   to   be   optimized   for   each  
application  and,  even   then,  viabilities  can  be   in   the   region  of  60%   for  differentiated  cells    
[35]  to  90%  for  ES  cells  [36].  One  possible  use  for  synthetic  biology  would  be  to  confer  on  
cells  an  inducible  state  that  makes  them  more  tolerant  of  printing,  for  example  by  altering  
the  cytoskeleton  to  make  it  more  flexible  (red  blood  cells,  for  example,  have  cytoskeletons  
that   make   then   very   tolerant   of   shear)   and   expressing   antioxidants   and   heat-­shock  
proteins.    Even  if  this  cannot  be  done,  having  the  cells  report  their  levels  of  stress  in  way  
that  can  be  detected  by   the  printer   (eg   fluorescence)  might  allow   the  use  of  closed-­loop  
contorol   in  which  the  printing  machine  will  operate  in  a  gentler  mode  when  this  becomes  
necessary.   A   second   application   might   be   to   confer   on   cells   superior   binding   to  
conveniently-­printed  materials  such  as  alginate,  because   the  currently  used   technique  of  
supplementing   these   artificial   materials   with   natural   animal   matrix   components   such   as  
collagen  can  complicate  the  printing  process  [34].    
 
The  other  major  method  of  tissue  engineering  eschews  bioprinting  and  instead  uses  cells'  
own  ability  to  organize  themsleves  into  organoids  [37-­39].  As  has  already  been  noted,  the  
structures   formed   tend   to   be   limited   to   those   that   resemble   existing   tissues,   the  
construction   involving  changes  of  gene  expression   in  sequences  similar   to  those  seen  in  
normal   development   in   a   process   that   has   been   termed      genetically   encoded   self-­
assembly   [40].   A   hybrid   approach   would   be   to   add   synthetic   biological   features   to   the  
existing   genetic   programme  so   that   self-­assembly   is   altered.  This  might   be  achieved  by  
altering  cell  motility  or  adhesion  [5].  More  spectacularly  and  flexibly,  it  has  proved  possible  
to  modify  cell  surfaces  so  that  they  carry  DNA  strands,  and  then  to  use  substrates  printed  
with  complementary  strands  so  that  each  cell   type  adheres  precisely  where   it   is  required  
[41].   In  principle,   it  may  be  possible  to  alter  preferences  of  cell-­cell  adhesion  in  this  way,  
even  without   a  matrix   (the  DNA  on   some   cell   surfaces   being   complementary   to   that   on  
other   cells).   By  methods   such   as   this,   different   cells   could   be   organized   a   specific  way  
before   they   begin   their   own   'evolved'   self-­organizing   programmes,   providing   a   more  
predictable  location  of  key  features.  
 
 
If   development   of   synthetic   biological   tools   for   patterning   and  morphogenesis   continues  
and   expands   then,   by   the   time   tissue   engineering   is   ready   to   meet   the   challenges   of  
producing  non-­natural  tissues,  the  required  technologies  may  be  in  place.  It  must  be  noted,  
though,   that   synthetic   biologists   entering   the   field   from   the   prokaryotic   world  might   find  
mammalian  systems   frustrating.  To  begin  with,   they  are   slow,  generation   times  being  of  
the   order   of   a   day   rather   than   tens   of   minutes.   Introduced   genes   are   also   subject   to  
epigenetic  effects,  particularly  gene  silencing   through  chromatin  modification.  Finally,   the  
natural   cell-­ell   interactions   that   are   so   critical   to   normal   development   and   to   organoid  
formation   will   still   be   up-­and-­running,   unless   the   synthetic   systems   actively   block   them.  
Given   our   still-­imprefect   knowledge   of   development,   these   signals,   and   the   cells'  
responses  to  them,  become  difficult  to  predict  when  cell  relationships  have  been  altered  by  
tissue   engineering.   Mammalian   synthetic   biology   remains   a   challenge   –   hopefully,   a  
challenge  that  will  prove  very  attractive  to  new  bio-­engineers  keen  to  prove  themselves.  
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Figure  1:  The  'embryological  cycle',  in  which  patterning  directs  differentiation  which  results  









Figure  2:  Synthetic  biological  modules  for  patterning  in  bacteria.  (a)  depicts  the  
repressilator  of  Elowitz  and  Leibler,  2000  that  generates  oscillations,  effectively  a  pattern  
in  time;;  (b)  depicts  a  module  that  interprets  a  gradient  of  signal  concentration  to  generate  a  









Figure  3:  De  novo  pattern  formation  by  cadherin-­driven  phase  separation  in  (a)  two  
dimensions  and  (b)  three  dimensions.  These  images  have  not  been  published  before  but  
they  are  from  the  same  data-­set  that  produced  the  figures  in  reference  33.    
  
  
  
  
 
 
